ENDRA Life Sciences Inc. (NDRA) Reports Q3 Loss, Misses Revenue Estimates

Published on November 15, 2021

ENDRA Life Sciences Inc. (NDRA) delivered earnings and revenue surprises of 14.29% and -100.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead...

Continue reading on website
Other news

Atlas Technical Consultants, Inc. (ATCX) Surpasses Q3 Earnings and Revenue Estimates

November 15, 2021
Atlas Technical Consultants, Inc. (ATCX) delivered earnings and revenue surprises of 100.00% and 3.06%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead...

Osmotica Pharmaceuticals (OSMT) Reports Q3 Loss, Misses Revenue Estimates

November 15, 2021
Osmotica Pharmaceuticals (OSMT) delivered earnings and revenue surprises of -16.67% and -7.96%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the...